STAT5BN642H is a driver mutation for T cell neoplasia
暂无分享,去创建一个
C. Bock | T. Rülicke | L. Kenner | R. Moriggl | S. Kubicek | V. Sexl | P. Valent | F. Grebien | M. Hengstschläger | Mathias Müller | M. Farlik | E. Grundschober | T. Kolbe | H. Pham | T. Javaheri | J. Pěnčík | H. Nivarthi | R. Grausenburger | Zahra Kazemi | B. Maurer | M. Prchal-Murphy | A. Boersma | M. Elabd | F. Halbritter | Auke Boersma | Harini Nivarthi
[1] Jun Liu,et al. CSF3R T618I, ASXL1 G942 fs and STAT5B N642H trimutation co‐contribute to a rare chronic neutrophilic leukaemia manifested by rapidly progressive leucocytosis, severe infections, persistent fever and deep venous thrombosis , 2018, British journal of haematology.
[2] Lisa Borghesi. Faculty Opinions recommendation of Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival. , 2017 .
[3] S. Bortoluzzi,et al. Genomic landscape characterization of large granular lymphocyte leukemia with a systems genetics approach , 2017, Leukemia.
[4] S. Bortoluzzi,et al. High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia. , 2016, Blood.
[5] G. Boucher,et al. Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors. , 2016, Blood.
[6] T. Karantanos,et al. Regulation of T Cell Differentiation and Function by EZH2 , 2016, Frontiers in immunology.
[7] S. Armstrong,et al. Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs. , 2016, Cancer cell.
[8] L. Hennighausen,et al. Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions , 2016, eLife.
[9] R. Siebert,et al. Genes encoding members of the JAK‐STAT pathway or epigenetic regulators are recurrently mutated in T‐cell prolymphocytic leukaemia , 2016, British journal of haematology.
[10] Dachuan Huang,et al. JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma , 2016, Leukemia.
[11] L. Cimmino,et al. The Impact of DNA Methylation in Hematopoietic Malignancies. , 2016, Trends in cancer.
[12] Nathan C. Sheffield,et al. LOLA: enrichment analysis for genomic region sets and regulatory elements in R and Bioconductor , 2015, Bioinform..
[13] T. Karantanos,et al. Regulation of T Cell Differentiation and Function by EZH2 , 2016, Front. Immunol..
[14] Naomi A. Sengamalay,et al. Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma , 2015, PloS one.
[15] L. Hennighausen,et al. Loss of EZH2 results in precocious mammary gland development and activation of STAT5-dependent genes , 2015, Nucleic acids research.
[16] E. Zandi,et al. Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis. , 2015, Immunity.
[17] M. Nakao,et al. STAT5 Orchestrates Local Epigenetic Changes for Chromatin Accessibility and Rearrangements by Direct Binding to the TCRγ Locus , 2015, The Journal of Immunology.
[18] T. Ikezoe,et al. STAT5A regulates DNMT3A in CD34(+)/CD38(-) AML cells. , 2015, Leukemia research.
[19] J. Biegel,et al. Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia. , 2015, Cancer genetics.
[20] Nathan C. Sheffield,et al. Epigenome Mapping Reveals Distinct Modes of Gene Regulation and Widespread Enhancer Reprogramming by the Oncogenic Fusion Protein EWS-FLI1 , 2015, Cell reports.
[21] Surasak Leelaudomlipi,et al. TOP2A Amplification and Overexpression in Hepatocellular Carcinoma Tissues , 2015, BioMed research international.
[22] Can Alkan,et al. Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells , 2015, Nature Communications.
[23] L. Kenner,et al. Stat5 gene dosage in T cells modulates CD8+ T‐cell homeostasis and attenuates contact hypersensitivity response in mice , 2015, Allergy.
[24] F. Speleman,et al. Epigenetics in T‐cell acute lymphoblastic leukemia , 2015, Immunological reviews.
[25] Q. Hu,et al. Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer , 2014, Oncotarget.
[26] W. Xue,et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma , 2014, Nature Genetics.
[27] Patrick Lombard,et al. CODEX: a next-generation sequencing experiment database for the haematopoietic and embryonic stem cell communities , 2014, Nucleic Acids Res..
[28] Suning Chen,et al. Rare occurrence of a STAT5B N642H mutation in adult T-cell acute lymphoblastic leukemia. , 2015, Cancer genetics.
[29] C. Alkan,et al. Activating mutations of STAT 5 B and STAT 3 in lymphomas derived from gdT or NK cells , 2015 .
[30] D. Sasseville,et al. Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression , 2014, Cell cycle.
[31] T. Rausch,et al. The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse , 2014, Haematologica.
[32] Thomas Lengauer,et al. Comprehensive Analysis of DNA Methylation Data with RnBeads , 2014, Nature Methods.
[33] K. Elenitoba-Johnson,et al. Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia. , 2014, Blood.
[34] T. Waldmann,et al. Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas , 2014, Leukemia.
[35] Heather L. Mulder,et al. The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes , 2014, Nature Communications.
[36] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[37] O. Lohi,et al. Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia , 2014, Leukemia.
[38] Michael P. Snyder,et al. Identification of STAT5A and STAT5B Target Genes in Human T Cells , 2014, PloS one.
[39] S. Orkin,et al. Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner. , 2014, Cell stem cell.
[40] L. Staudt,et al. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. , 2012, Blood.
[41] G. Crispatzu,et al. Models for mature T-cell lymphomas--a critical appraisal of experimental systems and their contribution to current T-cell tumorigenic concepts. , 2013, Critical reviews in oncology/hematology.
[42] S. Spicuglia,et al. Active STAT5 Regulates T-bet and Eomesodermin Expression in CD8 T Cells and Imprints a T-bet–Dependent Tc1 Program with Repressed IL-6/TGF-β1 Signaling , 2013, The Journal of Immunology.
[43] S. Mustjoki,et al. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. , 2013, Blood.
[44] Mingliang Xu,et al. The genetic and molecular basis of plant resistance to pathogens. , 2013, Journal of genetics and genomics = Yi chuan xue bao.
[45] Keunsoo Kang,et al. Comprehensive meta-analysis of Signal Transducers and Activators of Transcription (STAT) genomic binding patterns discerns cell-specific cis-regulatory modules , 2012, BMC Genomics.
[46] Yuka Kanno,et al. STATs Shape the Active Enhancer Landscape of T Cell Populations , 2012, Cell.
[47] Stein Aerts,et al. High Accuracy Mutation Detection in Leukemia on a Selected Panel of Cancer Genes , 2012, PloS one.
[48] Shan-qi Guo,et al. Histone Deacetylase Inhibition: An Important Mechanism in the Treatment of Lymphoma , 2012, Cancer biology & medicine.
[49] Peter A. Jones. Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.
[50] Kairong Cui,et al. Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function. , 2012, Immunity.
[51] J. Darnell,et al. The JAK-STAT pathway at twenty. , 2012, Immunity.
[52] M. Farrar,et al. The role of STAT5 in lymphocyte development and transformation. , 2012, Current opinion in immunology.
[53] G. Superti-Furga,et al. BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia. , 2012, Nature chemical biology.
[54] Christoph Bock,et al. RRBSMAP: a fast, accurate and user-friendly alignment tool for reduced representation bisulfite sequencing , 2012, Bioinform..
[55] M. Minden,et al. Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity. , 2012, Journal of medicinal chemistry.
[56] R. Moriggl,et al. Stat5 as a Hematopoietic Master Regulator for Differentiation and Neoplasia Development , 2012 .
[57] S. Daignault,et al. TET2 and DNMT3A Mutations in Human T-Cell Lymphoma , 2012 .
[58] A. Dinner,et al. Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2 , 2011, Nature Immunology.
[59] N. Nakagata. Cryopreservation of mouse spermatozoa and in vitro fertilization. , 2011, Methods in molecular biology.
[60] N. Friedman,et al. Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis , 2011, Cell.
[61] N. Luscombe,et al. Sensitized phenotypic screening identifies gene dosage sensitive region on chromosome 11 that predisposes to disease in mice , 2011, EMBO molecular medicine.
[62] G. Ferbeyre,et al. The role of Stat5 transcription factors as tumor suppressors or oncogenes. , 2011, Biochimica et biophysica acta.
[63] C. Scrideli,et al. research paper: Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia , 2010, British journal of haematology.
[64] F. Finkelman,et al. STAT5 Is Critical To Maintain Effector CD8+ T Cell Responses , 2010, The Journal of Immunology.
[65] W. Chan,et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. , 2010, Blood.
[66] T. Fioretos,et al. Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies , 2010, BMC Medical Genomics.
[67] Miyuki Abe,et al. STAT5 Activation Is Critical for the Transformation Mediated by Myeloproliferative Disorder-associated JAK2 V617F Mutant* , 2009, The Journal of Biological Chemistry.
[68] Wei Li,et al. BSMAP: whole genome bisulfite sequence MAPping program , 2009, BMC Bioinformatics.
[69] L. Hood,et al. Dysregulated gene expression networks in human acute myelogenous leukemia stem cells , 2009, Proceedings of the National Academy of Sciences.
[70] P. Lio’,et al. Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair , 2008, Cell.
[71] Jiahuai Han,et al. Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways. , 2008, Immunity.
[72] K. D. Bunting,et al. STAT5 signaling in normal and pathologic hematopoiesis. , 2007, Frontiers in bioscience : a journal and virtual library.
[73] Chunaram Choudhary,et al. Activation mechanisms of STAT5 by oncogenic Flt3-ITD. , 2006, Blood.
[74] L. Bystrykh,et al. The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. , 2006, Blood.
[75] A. Gnirke,et al. Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis , 2005, Nucleic acids research.
[76] M. Stratton,et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website , 2004, British Journal of Cancer.
[77] T. Rülicke. Pronuclear microinjection of mouse zygotes. , 2004, Methods in molecular biology.
[78] D. Baltimore,et al. Essential Role for STAT5 Signaling in CD25+CD4+ Regulatory T Cell Homeostasis and the Maintenance of Self-Tolerance1 , 2003, The Journal of Immunology.
[79] W. Leonard,et al. Stat5 Synergizes with T Cell Receptor/Antigen Stimulation in the Development of Lymphoblastic Lymphoma , 2003, The Journal of experimental medicine.
[80] L. Nie,et al. STAT5‐induced Id‐1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPβ , 2003, The EMBO journal.
[81] W. Leonard,et al. A Role for Stat5 in CD8+ T Cell Homeostasis , 2003, The Journal of Immunology.
[82] Daniel A Starr,et al. Human Zw10 and ROD are mitotic checkpoint proteins that bind to kinetochores , 2000, Nature Cell Biology.
[83] Jianzhu Chen,et al. Homeostasis-Stimulated Proliferation Drives Naive T Cells to Differentiate Directly into Memory T Cells , 2000, The Journal of experimental medicine.
[84] W. Leonard,et al. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines , 2000, Oncogene.
[85] Lukas Wagner,et al. A Greedy Algorithm for Aligning DNA Sequences , 2000, J. Comput. Biol..
[86] S. Jameson,et al. Homeostatic expansion and phenotypic conversion of naïve T cells in response to self peptide/MHC ligands. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[87] K. Brduscha-Riem,et al. Naïve cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipients: A pitfall for T cell memory studies? , 1999, European journal of immunology.
[88] A. W. Harris,et al. Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. , 1999, Blood.
[89] W. Leonard,et al. Stat5b Is Essential for Natural Killer Cell–mediated Proliferation and Cytolytic Activity , 1998, The Journal of experimental medicine.
[90] I. Hickson,et al. Structure and function of type II DNA topoisomerases. , 1994, The Biochemical journal.
[91] Michael McClelland,et al. Use of DNA methyltransferase/endonuclease enzyme combinations for megabase mapping of chromosomes. , 1992, Methods in enzymology.
[92] S. Ho,et al. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.